In pigs, Senecavirus A (SVA) causes a vesicular disease that is clinically indistinguishable from foot-and-mouth disease, vesicular stomatitis and swine vesicular disease.
, China (Qian, Fan, Qian, Chen, & Li, 2016; Wu et al., 2017) , Thailand (Saeng-Chuto, Rodtian, Temeeyasen, Wegner, & Nilubol, 2018) and Colombia (Sun, Vannucci, Knutson, Corzo, & Marthaler, 2017) have been demonstrated to be associated with porcine idiopathic vesicular disease since 2007. Clinically, SVA-infected pigs often present with anorexia, lethargy, lameness and vesicular lesions. Gross lesions are found on the oral mucosa, snout, nares, distal limbs, and in particular, around the coronary bands (Oliveira et al., 2017; Singh, Corner, Clark, Scherba, & Fredrickson, 2012) . These clinical signs are indistinguishable from those caused by other economically devastating transboundary pathogens, including foot-andmouth disease virus (FMDV), vesicular stomatitis virus (VSV) and swine vesicular disease virus (SVDV) (Segalés, Barcellos, Alfieri, Burrough, & Marthaler, 2017) . The differential diagnosis of these vesicular diseases depends on reliable laboratory detection methods.
Currently, a variety of diagnostic methods have been developed to diagnose SVA infection, including virus isolation (Qian et al., 2016) , immunohistochemistry (Leme, Oliveira, Alfieri, Headley, & Alfieri, 2016; Oliveira et al., 2017) , virus neutralization Yang et al., 2012) , indirect immunofluorescence assay (Dvorak et al., 2017) , enzyme-linked immunosorbent assay (Dvorak et al., 2017; Goolia et al., 2017) , RT-PCR (Leme et al., 2015) , RT-rPCR (Bracht, O'Hearn, Fabian, Barrette, & Sayed, 2016; Fowler et al., 2017; Gimenez-Lirola et al., 2016) and nested-PCR assays (Feronato et al., 2018) . Although each of these methods has played a vital role in SVA diagnosis, more sensitive and precise detection methods still need to be developed. Early and precise detection of SVA soon after the onset of infection is essential to prevent and control the spread of SVA.
As an emerging novel nucleic acid detection technology, droplet digital PCR (ddPCR) has shown several comparative advantages over its counterpart-real-time PCR (rPCR) (Hindson et al., 2013; Svobodova et al., 2015) . The main advantages of ddPCR include absolute quantification without reliance on calibration curves (Kuypers & Jerome, 2017) , precision even at very low template concentrations (Strain et al., 2013) , ability to detect minor target templates even against a background of an abundance of other normal sequences (Belmonte et al., 2016; Ren et al., 2018; Svobodova et al., 2015) and low susceptibility to PCR inhibitors (Hindson et al., 2013) . In a ddPCR assay, the reaction mixture including the target nucleic acid template is dispersed into a multitude of microdroplets called partitions, each of which might contain zero or one (or more) copies of the target molecule, as demonstrated by independent testing of microdroplets (Hudecova, 2015) . After PCR amplification, the number of positive partitions is counted, and the absolute number of target nucleic acids in the original sample is calculated using binomial Poisson statistics based on the ratio of positive to total partitions (Hindson et al., 2011; Pinheiro et al., 2012) .
To date, the ddPCR assay has been successfully applied for the detection of copy number variations (Bell, Usher, & McCarroll, 2018) , diagnosis of viral and bacterial infections (Gobert et al., 2018; Kuypers & Jerome, 2017; Yang et al., 2017) , quantification of miRNA (Cheng, Dong, Zhang, Zhao, & Li, 2018; Quan, Sauzade, & Brouzes, 2018) and identification of genetically modified organisms (Demeke & Dobnik, 2018) . In the present study, a novel RT-ddPCR assay, targeting the conserved viral polymerase 3D region, was established for the sensitive and specific detection of SVA. We also compared its performance in clinical sample detection with that of a TaqMan RT-rPCR assay. 
| MATERIALS AND METHODS

| Virus strains and viral genes
| Clinical samples
Forty-one pig serum samples and 93 tissue samples, including 24 lung, 11 spleen, 12 kidney, 26 intestine and 20 lymph node samples, were obtained from diseased pigs presenting with fever, vesicular lesions or lameness on 17 intensive pig farms in Hebei (Shijiazhuang, n = 2 farms; Tangshan, n = 2 farms; Chengde, n = 1 farm; Hengshui, n = 1 farm) and Guangdong (Guangzhou, n = 3 farms; Shenzhen, n = 3 farms; Dongguan, n = 2 farms; Shunde, n = 2 farms; Huizhou, n = 1 farm) Provinces in China during 2016-2017. Only one type of sample was collected from each individual pig.
| Primer and TaqMan probe design
Sixty-four SVA complete genomic sequences and six partial 3D gene sequences available in the GenBank database ( Figure 1 ) were aligned using BioEdit version 7.2.6.1 to identify the highly conserved regions.
The 3D gene was then selected, and the primers (SVA-3D-F1/R1) and TaqMan probe (SVA-3D-P1) for the RT-ddPCR were designed using the Primer Express software (version 3.0) (Applied Biosystems, Foster City, CA, USA). Two pairs of primers (SVA-3D-F/R and SVDV-3D-F/R) designed by Primer Premier 5.0 software (Premier Biosoft Int., Palo Alto, CA, USA) were used to prepare the standard cRNAs of the SVA and SVDV 3D genes. In addition, the primers (SVV3D-F1/R1) and TaqMan probe (SVV3D-Pr1) for a 3D-gene-based RT-rPCR assay for SVA were also synthesized as previously reported (Fowler et al., 2017) . All the primers and probes used in this study are summarized in Table 1 and were synthesized by the Beijing Genomics Institute (Beijing, China). 
| Nucleic acid extraction
| Preparation of standard cRNA
The SVA 3D gene was amplified by RT-PCR using viral RNA from the SVA GD01/2017 isolate as the template along with the primer pair SVA-3D-F and SVA-3D-R. The reaction was performed using a 
| RT-ddPCR assay
RT-ddPCR assays were performed in a 20-μl reaction volume using a One-step RT-ddPCR Advanced Kit for Probes (Bio-Rad, Hercules, CA, USA). The reaction mixture comprised 5 μl of Supermix, 2 μl of reverse transcriptase, 1 μl of 300 mM DTT, 800 nM of each SVA-3D-F1/R1 primer, 250 nM of SVA-3D-P1 probe and 1 μl of RNA template. Twenty microlitres of each reaction mixture was loaded into the sample wells of a DG8 ™ cartridge (Bio-Rad), followed by adding 70 μl of Droplet Generation Oil (Bio-Rad) per well into the corresponding oil wells. The cartridge was then placed in a QX200 ™ Droplet Generator (Bio-Rad), in which the reaction mixtures were partitioned into approximately 15,000 to 20,000 nanolitre-sized water-in-oil droplets. The generated droplets of each sample were carefully transferred into a 96-well PCR plate (Bio-Rad), which was subsequently heat-sealed with pierceable foil using a PX1 ™ PCR Plate Sealer (Bio-Rad). PCR amplifications were carried out using a thermal profile with an initial step at 45°C for 60 min and 95°C for 10 min, followed by 40 cycles of 95°C for 30 s and 60.5°C for 60 s, and one cycle of 98°C for 10 min, ending at 4°C. After amplification, the droplets from each well of the plate were read individually by a QX200 ™ Droplet Reader (Bio-Rad), and the data were analysed with QuantaSoft ™ software (Bio-Rad). Positive droplets containing amplified products were distinguished from negative droplets by applying a fluorescence amplitude threshold at the highest point of the negative droplet cluster. The reactions with more than 10,000 accepted droplets per well were used for analysis. The absolute initial copy number of target nucleic acid molecules within each sample was accurately approximated by calculating the ratio of positive to total droplets using Poisson statistics (Pinheiro et al., 2012) .
| RT-rPCR assay
The SVA 3D-gene-based RT-rPCR assay developed by Fowler and colleagues was performed using an Applied Biosystems 7500 Fast
Real-Time PCR Instrument as previously described (Fowler et al., 2017) . The corresponding primers (SVV3D-F1/R1) and probe (SVV3D-Pr1) are listed in Table 1 .
| Sensitivity analysis
The in vitro transcribed cRNA of the SVA GD01/2017 isolate was 10-fold serially diluted to achieve RNA concentrations ranging from 10 5 to 10 0 copies/μl. One microlitre of each dilution was then amplified by RT-ddPCR to determine the detection limit of the assay. For comparison, the RT-rPCR assay was performed in parallel using the same templates. Furthermore, to analyse the detection limit more accurately, eight independent runs for each assay were performed using the RNA standards, and the data were used for statistical analysis.
| Specificity analysis
The nucleic acid templates prepared from other pathogens including FMDV, VSV, SVDV, PRRSV, CSFV, PRV and PCV2 were detected by the RT-ddPCR assay. 
| Repeatability and reproducibility analysis
To assess the intra-assay repeatability and inter-assay reproducibility of the RT-ddPCR assay, serial dilutions of standard SVA cRNA ranging from 10 5 to 10 1 copies/μl were tested in triplicate in one run or in three independent runs on different days, and the coefficient of variation (CV) for the measurement of copy number per reaction was calculated.
| Evaluation of the RT-ddPCR assay with clinical samples
Total RNA extracted from each of the 41 pig serum samples and 93 tissue samples was detected by the RT-ddPCR assay. The results were compared with those obtained by the RT-rPCR assay that was performed in parallel.
| Statistical analysis
All statistical analyses and data plotting were performed using GraphPad Prism software (version 5.0; La Jolla, CA, USA). Kappa statistics were used to compare the detection results between the RT-ddPCR and the RT-rPCR assays and determine the level of agreement. The confidence limit for the statistical analyses was set at 95% (p < 0.05).
| RESULTS
| Optimization parameters of the RT-ddPCR assay
For optimization of the annealing temperature, the following temperatures (55.7, 56.6, 57.8, 59.1, 60.5, 61.8, 63.1 and 64.2°C) were tested in the RT-ddPCR assay using the reaction system and conditions recommended by the manufacturer (Bio-Rad). As shown in Figure 2 , the optimal annealing temperature was 60.5°C, which resulted in the greatest fluorescence amplitude difference between the positive (blue) and negative (grey) controls and generated the largest number of amplification products (number of positive droplets), and thus was selected as the optimal annealing temperature in the subsequent RT-ddPCR assays. Next, we optimized the primer and probe concentrations for the RT-ddPCR assay. Different combinations of primer and probe concentrations at 100 nM intervals from 500 to 1000 nM and 50 nM intervals from 100 to 350 nM, respectively, were assessed by the RT-ddPCR assay. Our results showed that the optimal concentrations for the primers and probe were 800 and 250 nM per reaction, respectively, generating the lowest fluorescence amplitude for the negative control (grey) with the same number of droplets for the positive control (blue) (data not shown).
| Linearity and sensitivity of the RT-ddPCR assay
Ten-fold serial dilutions of SVA cRNA ranging from 1 × 10 0 to 1 × 10 5 copies/μl were used as standards to construct the RT-ddPCR standard curve, and each concentration of template was tested in quadruplicate. As shown in Figure 3 , the trendline for the measured concentration showed a high degree of linearity with the starting concentration (R 2 = 0.9988). For the sensitivity analysis, the 10-fold serial dilutions of SVA cRNA were simultaneously detected by the RT-ddPCR assay and the RT-rPCR assay developed by Fowler and colleagues (Fowler et al., 2017) . As shown in Figure 4 , the detection limit of RT-ddPCR was determined to be 0.08 copies/μl, which is equivalent to 1.6 copies per reaction in a 20-μl volume. Further statistical analysis of the data from eight independent runs showed that the detection limit of RT-ddPCR was 1.53 ± 0.22 copies per reaction (n = 8). By contrast, the detection limit of the RT-rPCR was F I G U R E 3 Standard curve of the RT-ddPCR assay. Ten-fold serial dilutions of SVA cRNA ranging from 1 × 10 0 to 1 × 10 5 copies/μl were assessed by the RT-ddPCR assay in quadruplicate. The quantification correlation was obtained by plotting the log measured concentration against the log starting concentration. The R 2 value is 0.9988
15.72 ± 1.88 copies per reaction (n = 8) when using a cut-off detection limit of 40 cycles and was approximately about 10 times lower than that of the RT-ddPCR assay.
| Specificity of the RT-ddPCR assay
For the specificity analysis, nucleic acid templates prepared from other pathogens, including FMDV, VSV, SVDV, PRRSV, CSFV, PRV and PCV2, were detected by the RT-ddPCR assay. As shown in Figure 5 , only the SVA RNAs tested positive, while RNA from other pathogens tested negative. Further in silico analysis showed that the primers and probe for the SVA RT-ddPCR did not anneal to any other picornavirus or swine pathogens (data not shown). Collectively, these results indicate that the RT-ddPCR assay is specific for the detection of SVA.
| Repeatability and reproducibility of the RTddPCR assay
For the repeatability analysis, the serial dilutions of SVA cRNA were tested by RT-ddPCR in triplicate in one run. For the reproducibility analysis, the serial dilutions were tested by RT-ddPCR in three independent runs on different days. As shown in Table 2 , the intra-assay CV ranged from 2.69% to 8.16%, while the inter-assay CV ranged from 3.54% to 7.18%, indicating good repeatability and reproducibility of the RT-ddPCR assay.
| Evaluation of the RT-ddPCR assay with clinical samples
To evaluate the performance of the RT-ddPCR assay in the detection of SVA, 41 pig serum and 93 tissue samples were simultaneously detected by RT-ddPCR and RT-rPCR assays. The detection results of the RT-ddPCR assay were compared with those obtained with the RT-rPCR assay. As shown in Table 3 CV: coefficient of variation; Mean: the average copy number per reaction from three independent RT-ddPCR reactions; SD: standard deviation. 
| DISCUSSION
Although SVA was discovered decades ago (Hales et al., 2008) , it was not until 2007 that the association between SVA infection and porcine idiopathic vesicular disease was first reported in Canada (Pasma, Davidson, & Shaw, 2008) . As a result of the rapid increase in incidence and expansion into new geographic ranges, SVA is now considered an emerging infectious disease (Segalés et al., 2017) . Recent case reports from the United States (Canning et al., 2016; Zhang et al., 2015) , Brazil (Leme et al., 2015; Vannucci et al., 2015) , Canada (Xu et al., 2017) , China (Qian et al., 2016; Wu et al., 2017 ), Thailand (Saeng-Chuto et al., 2018 and Colombia provided evidence that SVA is a potential causative agent of idiopathic vesicular disease in pigs.
Moreover, experimental inoculation of pigs with contemporary SVA strains successfully reproduced the disease Joshi et al., 2016; Montiel et al., 2016) , further confirming that SVA is pathogenic in pigs. These findings suggest an evolution of the virus into a more virulent phenotype, which warrants further investigation. The contemporary SVA strains not only led to vesicular lesions in sows and finishing pigs but also resulted in high mortality in neonatal piglets (Leme et al., 2016; Segalés et al., 2017; Vannucci et al., 2015) , causing considerable economic losses to the swine industry worldwide. For better surveillance and control of this emerging virus, more sensitive and reliable diagnostic methods are needed.
As a third-generation PCR technique, ddPCR enables the absolute quantification of nucleic acids, including DNA and RNA, without the requirement for a calibration curve, unlike real-time PCR (Hindson et al., 2011 (Hindson et al., , 2013 . In the present study, we established a novel RT-ddPCR assay for the detection of SVA. To the best of our knowledge, this study is the first report of the establishment of an RT-ddPCR assay for SVA RNA detection. To guarantee optimal performance of the assay, 64 complete SVA genomic sequences and six partial 3D gene sequences currently available in the GenBank database were aligned during primer and probe design. The 3D gene was selected as the molecular target, for which one pair of primers and a corresponding probe were designed. After optimization of the parameters, the sensitivity and specificity of RT-ddPCR were evaluated. We used 10-fold dilutions of SVA cRNA standards ranging from 1 × 10 0 to 1 × 10 5 copies/μl to evaluate the dynamic range and linearity of RT-ddPCR. Our results demonstrated that the detection limit of SVA RT-ddPCR was 1.53 ± 0.22 copies per reaction (n = 8), which was approximately 10-fold higher than that of the RTrPCR assay developed by Fowler and colleagues (Fowler et al., 2017 These characteristics make the SVA RT-ddPCR assay more suitable for the early detection of SVA infection and thus confer benefits in terms of preventing and controlling the spread of the virus.
In addition to the advantages described above, we also found that the SVA RT-ddPCR assay started to lose linearity when the initial concentration of the SVA cRNA standards was higher than 1 × 10 5 copies/μl (data not shown), thereby presenting a relatively narrow linear dynamic range compared with the RT-rPCR assay. Our results were consistent with previous studies, in which investigators demonstrated that the upper limit of the dynamic range of ddPCR was 10 5 copies of target nucleic acid (Hindson et al., 2011; Pinheiro et al., 2012) . Once the droplets of ddPCR became saturated, the concentration of nucleic acid templates in samples calculated by the
Poisson algorithm according to the number of positive droplets would be higher than the actual result. Nevertheless, positive samples containing high concentrations of viral nucleic acids would still test positive, even if the detection values were slightly higher than the actual values. In general, qualitative assays rather than quantitative assays are widely used for the diagnosis of animal diseases.
In conclusion, a novel RT-ddPCR assay was developed based on the highly conserved 3D gene of SVA. This assay exhibited good sensitivity, specificity, repeatability and reproducibility, and thus could be applied as a robust diagnostic tool for the detection of SVA, even in samples with a low viral load. 
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